LSGGX
Price
$25.60
Change
-$0.18 (-0.70%)
Updated
Oct 7 closing price
Net Assets
143.46M
RPEBX
Price
$71.76
Change
-$0.41 (-0.57%)
Updated
Oct 7 closing price
Net Assets
164.4B
Interact to see
Advertisement

LSGGX vs RPEBX

Header iconLSGGX vs RPEBX Comparison
Open Charts LSGGX vs RPEBXBanner chart's image
Loomis Sayles Global Growth Y
Price$25.60
Change-$0.18 (-0.70%)
VolumeN/A
Net Assets143.46M
American Funds New Perspective R2E
Price$71.76
Change-$0.41 (-0.57%)
VolumeN/A
Net Assets164.4B
LSGGX vs RPEBX Comparison Chart in %
View a ticker or compare two or three
VS
LSGGX vs. RPEBX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSGGX is a Buy and RPEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 164B vs. LSGGX (143M). RPEBX pays higher dividends than LSGGX: RPEBX (0.12) vs LSGGX (0.00). LSGGX was incepted earlier than RPEBX: LSGGX (10 years) vs RPEBX (11 years). RPEBX (1.21) is less costly to investors than LSGGX (1.13). RPEBX is a more actively managed with annual turnover of: 24.00 vs. LSGGX (6.00). RPEBX has a lower initial minimum investment than LSGGX: RPEBX (250) vs LSGGX (100000). LSGGX annual gain was more profitable for investors over the last year : 27.56 vs. RPEBX (13.25). LSGGX return over 5 years is better than : 44.34 vs. RPEBX (33.50).
LSGGXRPEBXLSGGX / RPEBX
Total Expense Ratio0.951.2179%
Annual Report Gross Expense Ratio1.131.2193%
Fund Existence10 years11 years-
Gain YTD23.17218.867123%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets143M164B0%
Annual Yield % from dividends0.000.12-
Returns for 1 year27.5613.25208%
Returns for 3 years101.2561.68164%
Returns for 5 years44.3433.50132%
Returns for 10 yearsN/A92.90-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAPIX17.18N/A
N/A
Matthews Asia Dividend Investor
ITHSX57.86N/A
N/A
Hartford Capital Appreciation R4
SHPCX13.51N/A
N/A
Saratoga Health & Biotechnology C
IUESX30.91N/A
N/A
JPMorgan International Focus I
SCSIX43.50N/A
N/A
Sterling Capital SmCp Val R6